Medtronic 2015 Annual Report Download - page 101

Download and view the complete annual report

Please find page 101 of the 2015 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 166

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166

Medtronic plc
Notes to Consolidated Financial Statements (Continued)
Information regarding the Company’s consolidated balance sheets presentation at April 24, 2015 and April 25, 2014 is as follows:
April 24, 2015 April 25, 2014
(in millions) Investments Other Assets Investments Other Assets
Available-for-sale securities $ 14,560 $ 186 $ 12,771 $ 155
Trading securities 77 — 67 —
Cost method, equity method, and other investments — 520 — 666
Total $ 14,637 $ 706 $ 12,838 $ 821
The following tables show the gross unrealized losses and fair values of the Company’s available-for-sale securities that have
been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category as of April 24, 2015
and April 25, 2014:
April 24, 2015
Less than 12 Months More than 12 Months
(in millions) Fair Value
Unrealized
Losses Fair Value
Unrealized
Losses
Corporate debt securities $ 944 $ (9) $ 34 $ (1)
Auction rate securities — — 105 (4)
Mortgage-backed securities 346 (3) 206 (3)
U.S. government and agency securities 356 (1) 267 (3)
Debt funds 1,291 (109) 559 (41)
Marketable equity securities 4 (19) — —
Total $ 2,941 $ (141) $ 1,171 $ (52)
April 25, 2014
Less than 12 Months More than 12 Months
(in millions) Fair Value
Unrealized
Losses Fair Value
Unrealized
Losses
Corporate debt securities $ 1,601 $ (14) $ 50 $ (3)
Auction rate securities — — 97 (12)
Mortgage-backed securities 682 (7) 28 (1)
U.S. government and agency securities 1,500 (27) 46 (2)
Debt funds 1,224 (29) — —
Marketable equity securities 25 (13) — —
Total $ 5,032 $ (90) $ 221 $ (18)
Activity related to the Company’s investment portfolio is as follows:
Fiscal Year
2015 2014 2013
(in millions) Debt(a) Equity(b)(c) Debt(a) Equity(b) Debt(a) Equity(b)
Proceeds from sales $ 5,640 $ 250 $ 7,991 $ 120 $ 10,350 $ 161
Gross realized gains $ 33 $ 164 $ 15 $ 69 $ 59 $ 94
Gross realized losses $ (19) $ — $ (12) $ — $ (17) $ —
Impairment losses recognized $ — $ (29) $ (1) $ (9) $ — $ (21)
(a) Includes available-for-sale debt securities.
(b) Includes marketable equity securities, cost method, equity method, exchange-traded funds, and other investments.
(c) As a result of certain acquisitions that occurred during fiscal year 2015, the Company recognized a non-cash realized
gain of $41 million on its previously-held minority investments included in other expense, net on the consolidated
statement of income. Also, a realized gain on an equity method investment totaling $97 million is included in special
(gains) charges, net on the consolidated statement of income.
91